The Patent Finder

Ligand UK Development Limited

Also on record
Records under this name other than the patents Ligand UK Development Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 21 patents it holds.

Back to Ligand UK Development Limited

PatentTitleStatus Expires Confidence
US 8,163,747Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-Isopropyl-PHENYL)-4-(4-Morpholin-4-Ylmethyl-PHENYL)-ISOXAZOLE-3-Carboxylic Acid Ethylamide and Formulations Comprising These Forms
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,671,0592-Amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-ones
Formerly held
Term ended
Term ended Sep 28, 2026 · High confidence
Term endedTerm ended Sep 28, 2026High confidence
US 8,487,095Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms
Formerly held
Lapsed on the fee record
Ended Jul 16, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 16, 2025From the USPTO record
US 8,507,480Isoxazole compounds as inhibitors of heat shock proteins
Term ended
Term ended Dec 25, 2024 · From the USPTO record
Term endedTerm ended Dec 25, 2024From the USPTO record
US 7,705,027Isoxazole compounds as inhibitors of heat shock proteins
Term ended
Term ended Sep 24, 2024 · From the USPTO record
Term endedTerm ended Sep 24, 2024From the USPTO record
US 8,450,310Isoxazole compounds as inhibitors of heat shock proteins
Term ended
Ended no later than Feb 9, 2024 · From the USPTO record
Term endedEnded no later than Feb 9, 2024From the USPTO record
US 9,718,793Isoxazole compounds as inhibitors of heat shock proteins
Term ended
Ended no later than Feb 9, 2024 · From the USPTO record
Term endedEnded no later than Feb 9, 2024From the USPTO record
US 10,413,550Isoxazole compounds as inhibitors of heat shock proteins
Term ended
Ended no later than Feb 9, 2024 · From the USPTO record
Term endedEnded no later than Feb 9, 2024From the USPTO record
US 11,234,987Isoxazole compounds as inhibitors of heat shock proteins
Term ended
Ended no later than Feb 9, 2024 · From the USPTO record
Term endedEnded no later than Feb 9, 2024From the USPTO record
US 7,141,575Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
Term ended
Term ended May 15, 2022 · From the USPTO record
Term endedTerm ended May 15, 2022From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited